News Releases

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek™ Prostate Cancer Confirmation Test

February 25, 2019

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

February 21, 2019

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

February 13, 2019

Anixa Biosciences Conference Call Recording Available on Company Website

January 25, 2019

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

January 24, 2019

Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019

January 16, 2019

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

Latest News & Events

May 26, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

Read More...

May 20, 2021

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

Read More...

May 7, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

Read More...